Home » Response Biomedical Granted License by Health Canada to Market RSV Assay
Response Biomedical Granted License by Health Canada to Market RSV Assay
Response Biomedical Monday announced that it has been granted a Class 3 (near patient/point-of-care) Medical Device license by Health Canada to market its Ramp Respiratory Syncytial Virus (RSV) Assay in Canada.
MarketWatch
MarketWatch
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May